CTA
CMD

Carillon Tower Advisers’s Cantel Medical Corporation CMD Stock Holding History

Carillon Tower Advisers’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$23.3M Buy
295,116
+235,550
+395% +$13.8M 0.14% 213
2020
Q3 		$2.62M Buy
59,566
+10,826
+22% +$533K 0.03% 396
2020
Q2 		$2.16M Buy
48,740
+21,200
+77% +$791K 0.02% 438
2020
Q1 		$989K Sell
27,540
-2,100
-7% -$119K 0.01% 433
2019
Q4 		$2.1M Buy
+29,640
New +$2.15M 0.01% 456

Other funds holding CMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
LGP
Leonard Green & Partners Los Angeles, California $2.77B AUM 3.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return